PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

56 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Banjac, A. et al.: The cystine/cysteine cycle: A redox cycle regulating susceptibility versus resistance to cell death. Oncogene 27, 1618-1628 (2008)
22.
Ehrhardt, H.* et al.: Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells. Oncogene 27, 783-793 (2008)
23.
Engelmann, A.* ; Speidel, D.* ; Bornkamm, G.W. ; Deppert, W.* & Stocking, C.*: Gadd45β is a pro-survival factor associated with stress-resistant tumors. Oncogene 27, 1429-1438 (2008)
24.
Greif, P.A. ; Tizazu, B.* ; Krause, A.J. ; Kremmer, E. & Bohlander, S.K.: The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros. Oncogene 27, 2886-2896 (2008)
25.
Härtl, B.* ; Zeller, T.* ; Blanchette, P.* ; Kremmer, E. & Dobner, T.*: Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription. Oncogene 27, 3673-3684 (2008)
26.
Unger, K. et al.: Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. Oncogene 27, 4592-4602 (2008)
27.
Hausherr, A. et al.: Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases. Oncogene 26, 4987-4998 (2007)
28.
Thirunarayanan, N.* et al.: Enhanced tumorigenicity of fibroblasts transformed with human herpesvirus 8 chemokine receptor vGPCR by successive passage in nude and immunocompetent mice. Oncogene 26, 5702-5712 (2007)
29.
Trivedi, A.K.* et al.: Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene 26, 1789-1801 (2007)
30.
Djafarzadeh, R.* et al.: GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-mediated killing. Oncogene 25, 1496-1508 (2006)
31.
Dolznig Grebien, F.* et al.: Erythroid progenitor renewal versus differentiation: Genetic evidence for cell autonomous, essential functions of EpoR, STat5 and the GR. Oncogene 25, 2890-2900 (2006)
32.
Fröhlich Archangelo, L.* ; Gläsner, J.* ; Krause, A.* & Bohlander, S.K.: The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10. Oncogene 25, 4099-4109 (2006)
33.
Pazzaglia, S.* et al.: Linking DNA damage to medulloblastoma tumorigenesis in patched heterozygous knockout mice. Oncogene 25, 1165-1173 (2006)
34.
Dirmeier, U. et al.: Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24, 1711-1717 (2005)
35.
Weiss, C.* et al.: TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. Oncogene 24, 4975-4983 (2005)
36.
Yu, M.* et al.: PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation. Oncogene 24, 1982-1993 (2005)
37.
Kappler, R.* et al.: Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma. Oncogene 23, 8785-8795 (2004)
38.
Münz, M. et al.: The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23, 5748-5758 (2004)
39.
Schlosser, I. et al.: Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line. Oncogene 24, 1-5 (2004)
40.
Elsässer, A. et al.: The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner. Oncogene 22, 5646-57 (2003)